Recently, studies have investigated the significance of the Wnt/b-catenin pathway in prostate cancer. The transcriptional activity of the androgen receptor (AR) is modulated by interaction with coregulators, one of which is b-catenin. Curcumin, a dietary yellow pigment of Curcuma longa, has emerged as having a chemopreventive role. Although curcumin has been shown to inhibit AR expression, its molecular mechanism has not been fully elucidated. In this study, whether curcumin mediates the Wnt/b-catenin signaling pathway with regard to AR/b-catenin interactions was studied. Curcumin was shown to induce significant inhibition of AR expression in a dose-dependent manner. Marked curcumin-induced suppression of b-catenin was shown in the nuclear and cytoplasmic extracts as well as whole cell lysates. Further analysis revealed that phosphorylation of Akt and glycogen synthase kinase-3b were attenuated, but phosphorylated b-catenin was increased after curcumin treatment. Finally, cyclin D1 and c-myc, the target gene of the b-catenin/T-cell factor transcriptional complex, were also decreased. These findings suggest that curcumin modulates the Wnt/b-catenin signaling pathway and might have a significant role in mediating inhibitory effects on LNCaP prostate cancer cells.
Introduction
In 2009, the most common cancer expected to occur among men was reported to be prostate cancer in the United States. Prostate cancer alone accounted for 25% of all new diagnosed cancers and was the second leading cause of cancer-related deaths in men. 1 Evidence from epidemiological studies indicates that diet has a significant role in the development of prostate cancer. 2 Chemoprevention with natural or synthetic chemical compounds is an attractive strategy in prostate cancer because this cancer has a high prevalence in western population and relatively slow progression to a clinically significant cancer from an indolent or latent cancer. It has been well accepted that the androgenic stimuli over a long period can be contributed to the development of prostate cancer. Therefore, an effort to decrease the androgenic action might be a persuasive option for chemoprevention in prostate cancer.
Even though the cause of prostate cancer is largely unknown, the androgen receptor (AR) has an important role in the development and progression of prostate cancer. The transcriptional activity of AR is largely dependent on various coregulators. Aberrant regulation or expression of AR coregulators may contribute prostate cancer development and progression. 3 b-catenin, one of the potent coactivators, had been shown to interact directly with the AR as a significant coregulator. The biological significance of b-catenin in prostate cancer cells is actually exposed by the discovery of a proteinprotein interaction between AR and b-catenin. 4 Through this interaction, b-catenin not only selectively binds to AR, but also augments the ligand-dependent activity of AR in LNCaP cells. 5, 6 Androgens were shown to enhance the b-catenin to AR interaction, and the ligand-binding domain of AR was mapped to be responsible for this binding. 6 The dynamic interaction between AR and b-catenin was reported. In the presence of androgen, AR could enhance the nuclear translocation of b-catenin. 7 Recently, b-catenin to AR interactions showed a synergistic relationship between Wnt and the androgen signaling pathway in prostate cancer. 4 Therefore, accumulated evidence has shown a strong relationship between AR and b-catenin in prostate cancer.
The Wnt family constitutes highly conserved secreted glycoproteins that regulate a variety of developmental processes. 8, 9 The activation of Wnt signaling and its downstream component b-catenin have critical roles in a variety of cancers, including prostate cancer. 10 Despite the genetic mutations in b-catenin are rare in prostate cancer, however, there are multiple evidences for increased b-catenin/T-cell factor (TCF) activity because of the upregulation of b-catenin. 10 Wnt signal transduction ultimately results in the activation of genes regulated by the TCF/lymphoid enhancer factor family in the nucleus. The important molecule responsible for the canonical Wnt cascade is b-catenin, a cytoplasmic protein whose stability is regulated by the destruction complex consisting of axin, adenomatous polyposis coli and glycogen synthase kinase-3b (GSK-3b). In the absence of Wnt signals, a destruction complex promotes b-catenin phosphorylation by GSK-3b, which leads to subsequent ubiquitination and proteasomal degradation of b-catenin. Studies have shown that GSK-3b, a multifunctional serine/threonine kinase, is involved in a wide range of cellular processes ranging from glycogen metabolism to cell growth and differentiation.
11 GSK-3b is a critical, negative regulator both of phosphatidylinositol 3-kinase (PI3K)/Akt and Wnt signaling. The PI3K-induced activation of Akt results in the phosphorylation of a wide range of target proteins including GSK-3b, after which GSK-3b becomes inactive. In addition, exposure to Wnt signaling leads to inactivation of GSK-3b through an as yet unclear mechanism and results in dephosphorylation of b-catenin. Subsequently, dephosphorylated b-catenin accumulates in the cytoplasm and translocates to the nucleus, in which it can associate with TCF/lymphoid enhancer factor to activate transcription factors such as c-myc and cyclin D1. Therefore, inactivation of GSK-3b and the resulting stabilization of free b-catenin are critical steps in Wnt signaling. Accumulating evidence indicates that the Wnt/b-catenin signaling pathway has an important role in the development of prostate cancer. 10, [12] [13] [14] [15] Moreover, increased b-catenin activity has been found to be significantly correlated with a poor prognosis in patients with prostate cancer. [16] [17] [18] Curcumin, one of the most studied chemopreventive agents, is a natural ingredient of turmeric compounds extracted from Curcuma longa. Studies have shown that curcumin modulates numerous cell signaling pathways implicated in the growth and survival of various cancer cell types including prostate cancer. 19, 20 Although the mechanisms associated with curcumin for chemoprevention in prostate cancer have not been fully elucidated, it is conceivable that the effects are on the AR at least in part. [21] [22] [23] Curcumin has been shown to downregulate the expression of AR and AR-binding activity to the androgen-response element. 21, 22 In addition, curcumin inhibits PSA and its analog also acts as an AR antagonist. 23, 24 However, it is unclear how curcumin regulates the AR expression in prostate cancer.
In this study, in vitro assessment for the effects of curcumin on the expression of AR in prostate cancer cells was performed. In addition, the molecular mechanism by which curcumin inhibits Wnt/b-catenin signaling in the androgen-dependent LNCaP cells was investigated. ) b-catenin (#9562/ #9561), c-myc (#9402) and b-actin (#4967) were purchased from Cell Signaling (Beverly, MA, USA). Antibody for cyclin D1 (sc-717) was a product of Santa Cruz Biotech (Santa Cruz, CA, USA). Curcumin was stored as a 50 mM stock solution in dimethyl sulfoxide.
Materials and methods

Cell culture and materials
Measurement of cell viability (MTS assay)
The cells were cultured in flat-bottomed 96-well plates at a density of 1 Â 10 4 cells per well. After 24 h of incubation, to allow the cells to adhere, the culture medium was extracted and replaced with fresh medium containing a variety of curcumin concentrations, ranging from 10 to 100 mM, in a total volume of 100 ml. Control cells received only the vehicle (dimethyl sulfoxide). The cells were then incubated for 24 and 48 h in the CO 2 incubator. At the end of incubation, 20 ml of CellTiter 96 AQ ueous One Solution Reagent (Promega, Madison, WI, USA) was added to each well according to the manufacturer's instructions. After 4 h of incubation, the cell viability was determined by measuring the absorbance at 492 nm using a microplate reader (Biochrom, Cambridge, UK). The percent viability was determined as a fraction of the loss of cell viability in the cultures. Each of the assays was conducted in triplicate.
Preparation of total cell extract
LNCaP cells were treated with a different or fixed concentration of curcumin for the indicated time periods (1 and 24 h). Following treatment, the cells were lysed in a buffer containing 50 mM Tris-HCl/pH 7.5, 250 mM NaCl, 0.5% Triton X-100, 1 mM Na 3 VO 4 , 1 mM DTT, 1 mM PMSF and 2 mg ml -1 protease inhibitor. After the cells were vortexed gently for lysis, the cell debris was removed by centrifugation at 2600 g for 15 min.
Isolation of nuclear and cytoplasmic extract
The nuclear extraction was prepared using an NE-PER Nuclear Cytoplasmic Extraction Reagent kit (Pierce, Rockford, IL, USA) according to the manufacturer's instruction. Briefly, the treated cells were washed twice with cold PBS and centrifuged at 500 g for 3 min. The cell pellet was suspended in 200 ml of cytoplasmic extraction reagent I by vortexing. The suspension was incubated on ice for 10 min followed by the addition of 11 ml of a second cytoplasmic extraction reagent II, vortexed for 5 s, incubated on ice for 1 min and centrifuged for 5 min at 16 000 g. The supernatant fraction (cytoplasmic extract) was transferred to a pre-chilled tube. The insoluble pellet fraction, which contains crude nuclei, was resuspended in 100 ml of nuclear extraction reagent by vortexing Curcumin inhibits AR through Wnt/b-catenin signaling HY Choi et al during 15 s and incubated on ice for 10 min, then centrifuged for 10 min at 16 000 g. The resulting supernatant, constituting the nuclear extract, was used for the subsequent experiments.
Western blot analysis
Total cell lysates and nuclear or cytoplasmic proteins were isolated as described above. Equal amounts of the protein concentrations were quantified by the bicinchoninic acid assay (Pierce) and Ponceau S staining (nuclear proteins) or b-actin band (cytoplasmic or total cell lysates).
In brief, cell proteins were separated on an SDSpolyacrylamide gel. Following electrophoresis, the proteins were electrophoretically transferred to a nitrocellulose membrane. The blotted membranes were blocked overnight in 5% nonfat dry milk in Tris-buffered saline containing 0.1% Tween 20 and then incubated with the indicated primary antibodies for 2 h at room temperature. The blots were washed four times with Tris-buffered saline containing 0.1% Tween 20 and incubated for 1 h with horseradish peroxidase-conjugated anti-rabbit IgG antibody in clocking solution. The protein bands were detected using an enhanced chemiluminescence kit (Pierce). All blots were stripped and reprobed with b-actin to ensure equal loading of protein.
Each western blot analysis was performed in triplicate.
Statistical analysis
All data were presented as mean ± s.e.m. from three sets of independent experiments. Analysis of variance with Tukey's multiple comparisons was used to determine the statistical differences between the values for each sample and the respective control (Predictive Analytics SoftWare Statistics, version 17.0, SPSS, Chicago, IL, USA). A P-value of o0.05 was considered as the statistical significance level.
Results
Curcumin inhibited the proliferation of LNCaP prostate cancer cells
The biological effect of curcumin on the proliferation of LNCaP cells was measured by the MTS assay. Cell proliferation was inhibited with time in a dose-dependent manner after curcumin treatment (Figure 1) . The inhibitory effect of various concentrations of curcumin was determined by constructing a dose-response curve. The half-maximal inhibitory concentration (IC 50 ) of curcumin after 24 and 48 h treatment was 25.0 and 18.4 mM, respectively. Although the maximum reduction of proliferation was seen at curcumin concentrations above 50 mM, there was a less dramatic change in the decline at concentrations from 50 to 100 mM. At concentrations of curcumin 40 mM or greater, it seemed to have a difference when comparing the incubation time. However, it did not reach a statistically significance in each concentration between 24 and 48 h of treatment (P40.05). As a result, curcumin was shown to markedly suppress cell proliferation in the LNCaP cell lines depending on the curcumin concentration.
Curcumin suppressed the expression of the AR
To determine whether curcumin treatment of the LNCaP cells influenced the AR protein, the expression of AR treated with various concentrations of curcumin was examined. The relative expression of AR to curcumin treatment was compared for each concentration ( Figure 2) . The mean expressions of AR are significantly different among the different curcumin concentrations (Po0.001). As shown in Figure 2 , low concentrations of curcumin resulted in a little reduction in AR expression. However, it showed a significant inhibition of the AR in the cells that were treated with curcumin at doses of 20 mM or greater (Figure 2b ). The reduction of the AR treated with 20 and 25 mM of curcumin was found at levels of 52 and 84%, respectively, compared with the control.
Curcumin repressed the nuclear accumulation of b-catenin
The b-catenin exists in three cellular pools. Most of the b-catenin is to be found in the cell membrane in which it is associated with E-cadherin and a-catenin, involved in cell adhesion. A smaller pool of b-catenin is located in the nucleus and cytoplasm and mediates Wnt signaling. To evaluate the effect of curcumin on Wnt/b-catenin signaling pathway, we first examined the expression of total b-catenin in AR-positive prostate cancer cell line LNCaP. As shown in Figure 3 , the total b-catenin expression was reduced in the curcumin-treated whole cell lysates. This result provided the first line of evidence that curcumin could suppress endogenous b-catenin expression.
The central event in Wnt/b-catenin signaling is the stabilization and nuclear translocation of b-catenin, which binds to TCF in the nucleus. Therefore, we next investigated whether curcumin affected the subcellular expression and localization of b-catenin. There was a statistically significant difference of b-catenin expression between the different samples in each extract (Figure 3b ; P ¼ 0.001 in whole lysates, Po0.001 in cytoplasmic extracts, Po0.001 in nuclear extracts). Of note, more Curcumin inhibits AR through Wnt/b-catenin signaling HY Choi et al prominent reduction of b-catenin was found in the nuclear extracts than other extracts. Taken together, these results imply the direct suppressive effect of curcumin against the Wnt/b-catenin signaling pathway in LNCaP cells.
Curcumin inhibited the transcriptional activity of the Wnt/b-catenin signaling pathway
Curcumin was shown to reduce significantly intracellular accumulation of b-catenin in the preceding experiments. We subsequently examined whether curcumin mediates the expression of intermediates of Wnt/ b-catenin pathway. It is well known that intracellular b-catenin levels are regulated by GSK-3b-mediated phosphorylation on its serine and threonine residues. The PI3K-induced activation of Akt results in the phosphorylation of GSK-3b, after which GSK-3b becomes inactive. Inactivation of GSK-3b results in b-catenin stabilization because of decreased degradation. 11 To further elucidate the mechanism by which curcumin inhibits b-catenin, we assessed the Akt activation using a phosphorylation-specific antibody for Ser 473 . As shown in Figure 4 , the phosphorylation of Akt was inhibited by curcumin in LNCaP cells. In contrast, almost equal amounts of total Akt proteins were found in both curcumin treated and untreated cells. As GSK-3b is one of the major downstream targets of either PI3K/Akt or Wnt pathway, we next investigated whether curcumin also affected the phosphorylation of GSK-3b. The phosphorylation of GSK-3b was suppressed by curcumin treatment, whereas the total amount of GSK-3b protein showed no differences in the presence or absence of curcumin. The above results show that curcumin blocks the phosphorylation of Akt and GSK-3b proteins in LNCaP cells.
It has been shown that GSK-3b regulates the cellular levels of b-catenin. If the GSK-3b becomes inactive, b-catenin is escaped from targeting by GSK-3b. To evaluate the downstream effect of GSK-3b in LNCaP cells, we examined the phosphorylation state of b-catenin. As shown in Figure 4 , phosphorylated b-catenin, which is prone to undergo proteasomal Curcumin inhibits AR through Wnt/b-catenin signaling HY Choi et al degradation, was increased after curcumin treatment. Similarly in Figure 3 , the total b-catenin expression was reduced in the curcumin-treated cells. To further assess how curcumin contributed to prostate cell growth, the expression of cyclin D1 and c-myc were examined, which is a well-characterized downstream targets of the Wnt signaling pathway. Both cyclin D1 and c-myc were inhibited after 24 h of curcumin treatment (Figure 4) . After a short-term incubation with curcumin, there was a little change in the expression of Wnt/b-catenin signaling proteins. However, the findings were more pronounced after 24 h of exposure to curcumin. Taken together, these results suggested that curcumin might elicit its growth inhibitory effects through inhibition of Wnt/GSK-3b/ b-catenin pathway, which resulted in the destabilization of b-catenin proteins, downregulation of cyclin D1 and c-myc expression.
Discussion
Why prostate cancer is more prevalent in western populations than others is not clear; however, lifestyle including diet is known to have a major role. 2 Among the potential dietary factors associated with this disparity is turmeric (C. longa), a spice that is consumed frequently by southeast Asian people, a continent with a low incidence of prostate cancer. 20 Androgens bind to and activate the AR, which regulates prostate cancer cell proliferation and survival. Recently, it has been reported that curcumin inhibits the expression of AR as well as AR-related cofactors. [21] [22] [23] In this study, we also showed that curcumin was shown to decrease AR expression, in a dose-dependent manner. However, the molecular mechanism by which curcumin regulates the AR is not completely understood.
The transactivation of the AR depends on several cofactors. One coactivator is b-catenin, a well-known downstream effector of Wnt pathway. The identification of b-catenin, as an AR cofactor, substantiated a possible role of Wnt signaling in prostate cancer development and progression. 4, 10 Several lines of evidence have shown that b-catenin can co-localize with AR in the nucleus and enhance AR-mediated transcription through a proteinprotein interaction. 4 Another study has confirmed this result where enhanced androgen-mediated transcription with the overexpression of b-catenin was identified in prostate cancer cells. 16 In this sense, b-catenin is considered to be a ligand-dependent coactivator of AR transcription. Particularly, recent evidence of an AR/b-catenin interaction provided a direct link between androgen signaling and the Wnt pathway. 4 Therefore, there is mutual cross-talk between both of these signaling pathways that has important consequences in prostate cancer cell. In this study, we first revealed that curcumin treatment was shown to decrease AR expression. As b-catenin is coupled with AR as a coactivator, we examined whether curcumin affects the expression of b-catenin in each isolated cellular extract. As a result, curcumin was found to stimulate the reduction of both intracellular accumulation and nuclear translocation of b-catenin.
GSK-3b has been shown to be constitutively active in resting cells and regulates b-catenin degradation. GSK-3b can itself be phosphorylated and inactivated either through the endogenous activity of the canonical Wnt signaling pathway or PI3K/Akt signal. Both of these signaling pathways might be active in prostate cancer cell and they are certainly associated with more aggressive Curcumin inhibits AR through Wnt/b-catenin signaling HY Choi et al states of prostate cancer. 10, 25 In the 'Wnt-on' state, the Wnt ligand-frizzled receptor complex diminishes the activity of b-catenin degradation through an alternative multiprotein complex containing dishevelled protein that itself phosphorylates GSK-3b rendering it inactive. Moreover, the PI3K/Akt induces phosphorylation and inactivation of GSK-3b. Consequently, free b-catenin is able to enter the nucleus to complex with TCF/lymphoid enhancer factor and increased nuclear b-catenin elevates AR activity to stimulate prostate cancer cell growth. Recent studies have shown that curcumin inhibits PI3K/Akt signaling and thereby causes apoptosis. [26] [27] [28] In this study, we showed that curcumin suppressed phosphorylation of both Akt and GSK-3b. Moreover, on the other hand, curcumin induced increase of phosphorylated b-catenin, which is expected to undergo proteosomal degradation. As a consequence, curcumin could serve not only to prevent accumulation of b-catenin, but also to degrade target substance such as cyclin D1 and c-myc. Our study revealed that curcumin treatments attenuated the expression of phosphorylated GSK-3b; however, the precise mechanism of curcumin on the regulation of GSK-3b is still unclear. Therefore, it was speculated that curcumin might block expression of phosphorylated GSK-3b through inhibition of Akt activity or interaction with upstream regulators involved in Wnt/b-catenin pathway. Further studies for the regulation of curcumin among PI3K/Akt, Wnt/ b-catenin and androgen signaling pathways are needed.
To identify whether the presence of serum affected the inhibitory effects of curcumin on the products of the Wnt/b-catenin signaling pathway, the experiments were performed in both the serum-starved (1% fetal bovine serum) and serum-stimulated states (10% fetal bovine serum). However, as shown in Figures 3 and 4 , the serum-stimulated curcumin had no obvious differences with regard to the expression of the products of the Wnt/b-catenin signaling pathway. The interesting findings of this study are that the suppressive effects of curcumin on the b-catenin expression were to be remarkable after 24 h of exposure to curcumin. The ubiquitination process necessitates the factor b-transducin repeat-containing protein, which recognizes phosphorylated b-catenin and initiates its ubiquitin ligation. 10 In addition, the ubiquitin-proteasome protein degradation pathway is a steady-state process. 29 Therefore, it seems that the prolonged curcumin treatment may induce more accumulated effect on the ubiquitination compared with short-term treatment.
In this study, we provide experimental evidences supporting the role of curcumin as an antiandrogenic mechanism in LNCaP prostate cancer cells. The results here are presented that the curcumin induced the degradation of b-catenin through regulation of downstream intermediates in the Wnt/b-catenin pathway. Given the fact that b-catenin acts as a transcriptional coactivator of AR, these results provide evidence whereby curcumin can affect LNCaP cell proliferation and growth through modulation of both Wnt/b-catenin and androgen signaling.
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